0830 Registration 0900 Welcome Address   Section I Prostate Cancer Update 0910 Active Surveillance - Current Status 0925 Biochemical Recurrence - What / When / How to Treat 0940 Point-counterpoint: is Intermittent Hormonal Therapy the New Standard of Care? 1015 Opening Ceremony of The S.H. Ho Urology Centre     1040 Tea Break and Photo Taking     Section II What is New in Urological Surgery 1100 New Strategy for Prostatic Biopsy 1115 Extending Our Territory - Role of Radical Prostatectomy in High Risk Cancer 1130 Point-counterpoint: MIS cystectomy is the New standard for MIBC 1150 Surgical Options for >100gm Prostate   High Power PVP   Endoscopic Enucleation   Laparoscopic Enucleation     1220 How to Maximize the Functional Outcomes After Robotic Radical Prostatectomy     1235 Lunch     Section III Controversies in Premature Ejaculation 1315 Is PE Really an Important Condition in Asian-pacific Population 1340 Is the Current Diagnostic Test for Premature Ejaculation Accurate? 1400 Is Dapoxetine Really the Magic Drug for PE? 1415 Can PDE5 Inhibitors Be Used in PE? 1430 Real Life Clincial Case Discussion 1445 Question and Answer     1500 Tea Break     Parallel Session Section IV Voiding Dysfunction 1515 Understanding Nocturia 1530 Treatment for Nocturia Desmopressin Alpha-1D Inhibitor Antimuscarinic 1615 Is Efficacy of Male Sling for Treating Male Urinary Incontinence Overhyped 1630 Point-counterpoint: Is UDS Needed Before Male Incontinence Surgery     Section V New Technologies in Urology 1515 New Diagnostic Tools for Bladder Cancer 1530 Radiotherapy, Is the Newer the Better? 1545 Focal Therapy for Prostate Cancer, How Far Are We? 1600 Laparoscopic Total Intracorporeal Radical Cystectomy 1615 ED Treatment Beyond PDE5 Inhibitors 1630 Is Stem Cell Therapy a Hope for LUTS Management     1730 - 1830 LKEC Lecture Prostate Cancer Screening - are We Helping or Harming Our Patients?